AdvanSix (ASIX) Stock Rating Lowered by Zacks Investment Research
AdvanSix (NYSE:ASIX) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Monday.
According to Zacks, “AdvanSix Inc. is a producer and supplier of Nylon 6 materials. The company’s polymer resin sold under the Aegis(R) brand to produce engineered plastics, fibers, filaments and films which in turn used in end products such as automotive and electronic components, carpets, sports apparel, fishing nets and food as well as industrial packaging. AdvanSix also produces caprolactam, the main feedstock for producing nylon; Caprannylon film(R); Sulf-N (R) ammonium sulfate fertilizers and chemical intermediates, including phenol, acetone, and Nadone (R) cyclohexanone. AdvanSix Inc. is based in Morris Plains, United States. “
Other equities analysts have also issued research reports about the company. ValuEngine lowered AdvanSix from a “buy” rating to a “hold” rating in a research note on Friday, June 1st. Cowen reduced their price objective on AdvanSix from $47.00 to $41.00 and set an “outperform” rating for the company in a research note on Thursday, April 12th.
AdvanSix (NYSE:ASIX) last released its quarterly earnings data on Friday, May 4th. The company reported $0.37 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.26 by $0.11. The business had revenue of $359.20 million during the quarter, compared to analyst estimates of $368.45 million. AdvanSix had a return on equity of 24.00% and a net margin of 8.99%. The company’s revenue was down 4.6% compared to the same quarter last year. analysts forecast that AdvanSix will post 3.24 earnings per share for the current year.
In other AdvanSix news, Director Michael Marberry bought 1,398 shares of the company’s stock in a transaction dated Monday, May 7th. The shares were purchased at an average cost of $35.74 per share, for a total transaction of $49,964.52. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders have bought a total of 4,150 shares of company stock worth $149,915 over the last 90 days. Insiders own 0.22% of the company’s stock.
A number of hedge funds have recently bought and sold shares of the stock. BlackRock Inc. boosted its holdings in AdvanSix by 1.0% in the 4th quarter. BlackRock Inc. now owns 4,068,705 shares of the company’s stock worth $171,172,000 after buying an additional 41,945 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of AdvanSix by 18.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 617,497 shares of the company’s stock worth $21,477,000 after purchasing an additional 97,836 shares during the last quarter. Loomis Sayles & Co. L P boosted its holdings in shares of AdvanSix by 1.3% during the 1st quarter. Loomis Sayles & Co. L P now owns 510,620 shares of the company’s stock worth $17,759,000 after purchasing an additional 6,629 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of AdvanSix by 7.1% during the 4th quarter. Bank of New York Mellon Corp now owns 365,023 shares of the company’s stock worth $15,358,000 after purchasing an additional 24,058 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in shares of AdvanSix by 37.7% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 360,128 shares of the company’s stock worth $15,151,000 after purchasing an additional 98,545 shares during the last quarter. Institutional investors own 76.07% of the company’s stock.
AdvanSix Company Profile
AdvanSix Inc manufactures and sells polymer resins in the United States. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce engineered plastics, fibers, filaments, and films. The company also provides caprolactam, ammonium sulfate fertilizers, and acetone, as well as other intermediate chemicals, including phenol, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, cyclohexanol, acetaldehyde oxime, 2-pentanone oxime, sulfuric acid, ammonia, and carbon dioxide.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.